Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder in premenopausal women, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Patients frequently present comorbidities, including obesity, insulin resistance, and impaired glucose and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastnak, Lara, Herman, Rok, Ferjan, Simona, Janež, Andrej, Jensterle, Mojca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672473/
https://www.ncbi.nlm.nih.gov/pubmed/38004264
http://dx.doi.org/10.3390/life13112124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672473/
https://www.ncbi.nlm.nih.gov/pubmed/38004264
http://dx.doi.org/10.3390/life13112124

Ejemplares similares